Mark Doak

Mark Doak serves on the Board of Directors of CELLTREAT Scientific Products, bringing 45 years of experience and executive leadership in the life science tools and analytical instruments industry. Former Senior Vice President at Agilent Technologies and President of Agilent CrossLab, Mark founded and scaled CrossLab into a $2.6 billion global strategic business unit business spanning supplies, chemistries, instrument services, software, and lab enterprise solutions.  His board-level expertise encompasses recurring revenue growth, M&A and private equity advisory, global commercial strategy, and digital operations.